Mid-Region Pro-Hormone Markers for Diagnosis and Prognosis in Acute Dyspnea
Top Cited Papers
- 1 May 2010
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 55 (19) , 2062-2076
- https://doi.org/10.1016/j.jacc.2010.02.025
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Natriuretic Peptides in Acute Coronary Syndromes: Prognostic Value and Clinical ImplicationsCongestive Heart Failure, 2008
- Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyondStatistics in Medicine, 2007
- Midregional Pro-A-Type Natriuretic Peptide Measurements for Diagnosis of Acute Destabilized Heart Failure in Short-of-Breath Patients: Comparison with B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNPClinical Chemistry, 2006
- Measurement of Midregional Proadrenomedullin in Plasma with an Immunoluminometric AssayClinical Chemistry, 2005
- Role of N-Terminal Pro-B-Type Natriuretic Peptide in Risk Stratification in Patients Presenting in the Emergency RoomClinical Chemistry, 2005
- Identification of an Adrenomedullin precursor fragment in plasma of sepsis patientsPeptides, 2004
- Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute DyspneaNew England Journal of Medicine, 2004
- Immunoluminometric Assay for the Midregion of Pro-Atrial Natriuretic Peptide in Human PlasmaClinical Chemistry, 2004
- Increased plasma levels of adrenomedullin in patients with heart failurePublished by Elsevier ,2000
- Effects of prehospital medications on mortality and length of stay in congestive heart failureAnnals of Emergency Medicine, 1992